webinar register page

ICRG Webinar: Pharmacotherapy Treatment of Gambling Disorder
Gambling disorder, previously termed pathological gambling, has been recognized as a formal disorder in the Diagnostic and Statistical Manual since 1980. Currently, behavioral therapies and self-help groups like Gamblers Anonymous are the main treatment/intervention approaches utilized. While multiple medications have been tested in clinical trials for their efficacy and tolerability in the treatment of gambling disorder, no drug has an FDA indication for treating the condition. Data suggest that the vast majority of individuals with gambling disorder (more than 95%) have one or more co-occurring psychiatric disorder. As such, in clinical practice, selection of the most appropriate medication for treating individuals may be guided by co-occurring disorders. Data suggest that targeting these co-occurring disorders may bring benefits in both the co-occurring and gambling domains. In this webinar, a current understanding of the data supporting the use of medications in the treatment of people with gambling disorder will be presented.

Learning objectives:
1. Appreciate the variety and complexities of co-occurring gambling and other psychiatric disorders.
2. Understand the evidence base for the use of medications in the treatment of people with gambling disorder given the frequently co-occurring psychiatric conditions.
3. Learn how different classes of medications (e.g., opioid receptor antagonists, mood stabilizers, serotonin reuptake inhibitors) and nutraceuticals (e.g., n-acetyl cysteine) may hold promise in the treatment of people with gambling disorder, particularly those with co-occurring disorders.

Dr. Marc N. Potenza, MD, PhD,
Yale University School of Medicine


* Required information